ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Pulmonary Disease

Top Pulmonary Disease Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GORDON WOLFE MD

Pulmonary Disease

10,298

$667K

514
436 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 60%

$65
Average prescription price

Avg: $176

JAMES HATCHER MD

Pulmonary Disease

9,918

$701K

197
151 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 60%

$71
Average prescription price

Avg: $176

ROMALDO DESOUZA M.D.

Pulmonary Disease

9,129

$638K

254
225 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 60%

$70
Average prescription price

Avg: $176

MICHELE BALLOU MD

Pulmonary Disease

7,619

$730K

354
266 are 65+

14%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 60%

$96
Average prescription price

Avg: $176

WILLIAM HENDERSON M.D.

Pulmonary Disease

5,267

$749K

611
442 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 60%

$142
Average prescription price

Avg: $176

AKLILU DEGENE MD

Pulmonary Disease

5,243

$793K

506
407 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 60%

$151
Average prescription price

Avg: $176

DAVID JONES MD

Pulmonary Disease

4,725

$396K

334
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 60%

$84
Average prescription price

Avg: $176

MING CHIU M.D.

Pulmonary Disease

4,640

$270K

248
184 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 60%

$58
Average prescription price

Avg: $176

JAMES MCDANIEL MD

Pulmonary Disease

4,220

$301K

275
216 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 60%

$71
Average prescription price

Avg: $176

THOMAS MURPHY MD

Pulmonary Disease

4,102

$412K

303
241 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 60%

$101
Average prescription price

Avg: $176

JOHN WHITE M.D.

Pulmonary Disease

4,056

$542K

503
328 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 60%

$134
Average prescription price

Avg: $176

FELIX DIPINTO M.D.

Pulmonary Disease

3,796

$226K

188
157 are 65+

19%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 60%

$60
Average prescription price

Avg: $176

GEORGE TEEKAH MD

Pulmonary Disease

3,660

$219K

219
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 60%

$60
Average prescription price

Avg: $176

BENJAMIN LEWIS MD

Pulmonary Disease

3,577

$371K

426
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 60%

$104
Average prescription price

Avg: $176

CUDDALORE VASUDEVAN M. D.

Pulmonary Disease

3,453

$400K

307
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 60%

$116
Average prescription price

Avg: $176

JAMES WITTEN MD

Pulmonary Disease

3,437

$591K

360
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 60%

$172
Average prescription price

Avg: $176

JEFFREY FORMAN MD

Pulmonary Disease

3,175

$349K

420
302 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 60%

$110
Average prescription price

Avg: $176

JOHN LESLIE MD

Pulmonary Disease

3,112

$775K

396
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

88%
prescriptions for brand name drugs

Avg: 60%

$249
Average prescription price

Avg: $176

JEFFREY LESSAR MD

Pulmonary Disease

2,898

$605K

432
322 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 60%

$209
Average prescription price

Avg: $176

WILLIAM HAMMOND M. D.

Pulmonary Disease

2,880

$385K

296
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 60%

$134
Average prescription price

Avg: $176

THOMAS O NEILL M.D.

Pulmonary Disease

2,808

$336K

341
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 60%

$120
Average prescription price

Avg: $176

NELSON GREENE MD

Pulmonary Disease

2,456

$429K

332
270 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 60%

$175
Average prescription price

Avg: $176

ROBERT KEELEY M.D.

Pulmonary Disease

2,415

$437K

314
243 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 60%

$181
Average prescription price

Avg: $176

PHONG NGUYEN M.D.

Pulmonary Disease

2,402

$620K

411
353 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

54%
prescriptions for brand name drugs

Avg: 60%

$258
Average prescription price

Avg: $176

ASHOK CHAUHAN M.D.,

Pulmonary Disease

2,359

$164K

111
98 are 65+

12%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 60%

$69
Average prescription price

Avg: $176

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank